Multi-institutional study on cytoreuctive nephrectomy for unresctable or metastatic renal cell carcinoma

JRCT ID: jRCT1040220068

Registered date:07/10/2022

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: metastatic renal cell carcinoma
• Date of first enrollment: 07/10/2022
• Target sample size: 500
• Study type: Observational

Outcome(s)

• Primary Outcome: overall survival

Secondary Outcome

Best overall response, progression-free survival, response rate, duration of response, safety, clinical usefulness rate
Patient Factors Affecting Response to Primary Resection and Adverse Events

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

(i) Patients over 20 years old with metastatic renal cancer
(ii) Inpatients and outpatients

Exclude criteria

(1) Patients who are deemed ineligible for participation in this study by the principal investigator or subinvestigator of the medical institution where this study is conducted
(ii) Patients who have requested refusal of the research use of their information by opting out.

Related Information

• Primary Sponsor: Kumada Naotaka